BerganKDV Wealth Management’s Moderna MRNA Stock Holding History

BerganKDV Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$6.8K	Sell	56 -444	-89%	-$59.2K	﹤0.01%	583
2023 Q1	$76.8K	Buy	500 +477	+2,074%	+$78.7K	0.01%	343
2022 Q4	$4.13K	Buy	23 +1	+5%	+$164	﹤0.01%	700
2022 Q3	$3K	Hold	22	–	–	﹤0.01%	765
2022 Q2	$3K	Sell	22 -803	-97%	-$115K	﹤0.01%	779
2022 Q1	$142K	Buy	825 +801	+3,338%	+$135K	0.02%	275
2021 Q4	$6K	Hold	24	–	–	﹤0.01%	757
2021 Q3	$9K	Hold	24	–	–	﹤0.01%	657
2021 Q2	$6K	Hold	24	–	–	﹤0.01%	681
2021 Q1	$3K	Buy	24 +1	+4%	+$145	﹤0.01%	742
2020 Q4	$2K	Buy	23 +7	+44%	+$708	﹤0.01%	787
2020 Q3	$1K	Sell	16 -107	-87%	-$7.46K	﹤0.01%	836
2020 Q2	$8K	Buy	+123	New	+$6.74K	﹤0.01%	569

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BerganKDV Wealth Management's MRNA Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Moderna (MRNA) stake by 89% in Q2 2023, selling an estimated $59.2K and leaving 56 shares worth $6.8K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

BerganKDV Wealth Management first reported a position in MRNA in Q2 2020 and has held it in 13 quarters since. The position peaked at $142K in Q1 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

BerganKDV Wealth Management held 56 shares of Moderna worth $6.8K as of Q2 2023.
BerganKDV Wealth Management sold 444 Moderna shares in Q2 2023, an estimated $59.2K.
Moderna made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #583 holding.
BerganKDV Wealth Management first reported a position in Moderna in Q2 2020 and has held it in 13 quarters since.
BerganKDV Wealth Management's Moderna position peaked at $142K in Q1 2022.
965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.